RSV in infant - Nursing Case Study

Pathophysiology

• Primary mechanism: RSV targets epithelial cells in the infant's lower respiratory tract, leading to cell death and sloughing. This damage results in inflammation and edema, which narrow the small airways (bronchioles), causing obstructive symptoms.

• Secondary mechanism: The virus triggers an excessive immune response, further exacerbating airway obstruction. The influx of immune cells, particularly neutrophils, increases mucus production, leading to mucus plugging and impaired gas exchange.

• Key complication: These processes can culminate in bronchiolitis, characterized by wheezing, hypoxia, and respiratory distress. In severe cases, it can cause acute respiratory failure, necessitating close monitoring and supportive care.

Patient Profile

Demographics:

6 months old, male, n/a

History:

• Key past medical history: Born at 36 weeks gestation, history of mild GERD

• Current medications: Omeprazole for GERD

• Allergies: None

Current Presentation:

• Chief complaint: Difficulty breathing, worsening cough

• Key symptoms: Wheezing, nasal flaring, lethargy, decreased appetite

• Vital signs: Temperature 101.3°F (38.5°C), Heart rate 160 bpm, Respiratory rate 60 breaths per minute, Oxygen saturation 89% on room air

Section 1

Change in Patient Status:

As the infant is monitored in the pediatric unit, there is a noticeable change in his clinical status. Despite initial interventions with supplemental oxygen and nebulized bronchodilators, his respiratory distress appears to be escalating. The infant's respiratory rate has increased to 70 breaths per minute, and there is evident use of accessory muscles, with intercostal retractions becoming more prominent. His oxygen saturation, even with supplemental oxygen, remains precarious, fluctuating around 92%. Auscultation reveals diminished breath sounds bilaterally, particularly in the lower lung fields, suggesting worsening obstruction and possible atelectasis.

In addition to respiratory concerns, the infant's lethargy has deepened. He is increasingly difficult to arouse, responding less to stimuli, and his decreased oral intake has resulted in signs of dehydration. A capillary refill time of over three seconds and a drop in urine output are noted, indicating compromised perfusion and fluid status. His heart rate has climbed to 180 bpm, a compensatory response to hypoxia and dehydration.

The medical team is prompted to escalate care. A chest X-ray is ordered to assess the extent of lung involvement, looking for signs of consolidation or atelectasis. Arterial blood gases are drawn, revealing respiratory acidosis; the pH is 7.25, with elevated pCO2 levels, confirming inadequate ventilation. This change in status necessitates the consideration of more aggressive interventions, such as high-flow nasal cannula or non-invasive ventilation, to improve gas exchange and relieve respiratory distress. The team must also address the infant's hydration status with IV fluids to support perfusion and prevent further deterioration, while preparing for possible transfer to a higher level of care if respiratory support becomes insufficient.

Section 2

As the medical team implements more aggressive interventions, the infant's clinical status continues to evolve. High-flow nasal cannula is initiated, delivering heated and humidified oxygen at a higher flow rate to help alleviate the respiratory distress. However, despite this escalation in respiratory support, the infant's condition shows only marginal improvement. His respiratory rate remains elevated at 65 breaths per minute, and the use of accessory muscles continues unabated, highlighting the severity of his respiratory compromise. His oxygen saturation stabilizes slightly at 94%, but only with the high-flow system in place.

The chest X-ray reveals bilateral patchy infiltrates, consistent with viral pneumonia, and areas of atelectasis in the lower lobes, confirming the suspected complications. The arterial blood gas analysis, repeated after the initiation of high-flow therapy, shows a slight improvement in pH to 7.30, but the pCO2 remains elevated, indicating ongoing respiratory acidosis and inadequate ventilation. These findings suggest that the current interventions may not be sufficient to fully reverse the respiratory compromise, necessitating further evaluation of potential causes and interventions.

In parallel, the infant's hydration status is addressed with an IV fluid bolus, aimed at correcting dehydration and improving perfusion. His heart rate decreases slightly to 170 bpm, and capillary refill time improves to three seconds, indicative of a positive response to fluid resuscitation. Despite these interventions, the infant's lethargy persists, and he remains difficult to arouse, raising concerns about potential central nervous system involvement or the need for more invasive respiratory support. The medical team considers the possibility of transferring the infant to the pediatric intensive care unit for closer monitoring and potential intubation if his condition does not stabilize. This decision-making process requires careful weighing of the risks and benefits of advanced respiratory support against the infant's current clinical trajectory.

Section 3

As the medical team continues to monitor the infant, a new complication emerges. Despite the high-flow nasal cannula and fluid resuscitation, the infant's respiratory distress persists, and he begins to exhibit signs of increased work of breathing. His respiratory rate now fluctuates between 70 and 75 breaths per minute, and intercostal retractions become more pronounced. The infant's oxygen saturation dips to 92% intermittently, even with high-flow oxygen support, suggesting that his respiratory drive is becoming increasingly compromised. Auscultation reveals diminished breath sounds in the lower lobes, raising concerns about worsening atelectasis or even potential pneumothorax.

New diagnostic results from a repeat arterial blood gas analysis reveal a concerning trend. The pH has decreased slightly to 7.28, and the pCO2 has risen to 55 mmHg, indicating worsening respiratory acidosis. These findings suggest that the infant's ventilation is becoming increasingly inadequate, and his ability to clear carbon dioxide is diminishing. The team also notes a slight increase in serum lactate levels to 3.5 mmol/L, possibly reflecting tissue hypoxia or increased metabolic demand due to the persistent respiratory effort. Given these developments, the team must reassess their approach, considering more invasive interventions to prevent further deterioration.

With the infant's clinical status exhibiting signs of potential respiratory failure, the decision to transfer him to the pediatric intensive care unit becomes imminent. The need for closer monitoring and the possibility of mechanical ventilation are weighed against the risks of delayed intervention. The team discusses the potential benefits of intubation to provide controlled ventilation and to alleviate the infant's respiratory burden. This decision underscores the critical importance of timely and effective escalation in care to stabilize the infant and prevent further complications, setting the stage for the next phase of his management and recovery.

Section 4

As the infant is transferred to the pediatric intensive care unit, the medical team initiates a comprehensive assessment to evaluate his current condition and guide further management. Upon arrival, the infant's vital signs reveal a heart rate of 180 beats per minute and persistent tachypnea, with respiratory rates consistently between 68 to 72 breaths per minute, despite the use of high-flow nasal cannula. Oxygen saturation remains precarious, intermittently dropping to 90% during periods of agitation or increased respiratory effort. Physical examination confirms pronounced intercostal and subcostal retractions, suggesting significant respiratory muscle fatigue. The infant's skin appears mottled with cool extremities, indicating possible peripheral vasoconstriction secondary to increased sympathetic activity.

The latest chest X-ray provides additional insights, revealing bilateral patchy infiltrates and significant areas of atelectasis in the dependent lower lung zones. The team discusses the possibility of a developing pneumothorax, but the X-ray does not show definitive evidence of this complication. However, the diminished breath sounds in the lower lobes suggest either worsening atelectasis or the development of a small, undetected pneumothorax. In response to these findings, the team orders a bedside ultrasound to further evaluate the lung fields for any occult pneumothorax or pleural effusion that might be contributing to the infant's respiratory distress.

Recognizing the urgency of the situation, the team deliberates the next steps carefully. The infant's persistent respiratory acidosis and rising lactate levels, now at 4.0 mmol/L, underscore the need for immediate intervention to prevent further respiratory compromise. A decision is made to proceed with intubation and mechanical ventilation to ensure adequate ventilation and oxygenation, relieving the infant's respiratory muscles and allowing for improved clearance of carbon dioxide. This critical intervention is expected to stabilize the infant's respiratory status and provide a platform for recovery, with a multidisciplinary team on standby to manage potential complications and support the infant's transition through this critical phase of care.

Section 5

As the medical team proceeds with intubation and mechanical ventilation, the infant's condition shows initial signs of stabilization. Vital signs post-intubation indicate a reduction in heart rate to 160 beats per minute and a more regularized respiratory pattern due to controlled ventilation settings. Oxygen saturation improves, consistently ranging between 94% to 96%, suggesting effective oxygenation. Despite these encouraging signs, the team remains vigilant, closely monitoring for any new complications or changes in status.

Shortly after stabilization, the results from the bedside lung ultrasound return, confirming the presence of small bilateral pleural effusions but no definitive evidence of pneumothorax. These findings correlate with the infant's ongoing respiratory distress and hint at fluid overload or worsening inflammatory response within the lung tissues. In response, the team initiates a diuretic regimen to manage the pleural effusions and reduce lung congestion, while continuing to provide supportive care.

However, as the hours pass, a new challenge emerges. Laboratory tests reveal a progressive increase in inflammatory markers, including a C-reactive protein level that has risen to 120 mg/L. Concurrently, the infant develops a fever, with body temperature spiking to 38.5°C. These developments raise concerns about a potential secondary bacterial infection, possibly complicating the viral process. Blood cultures are drawn, and empirical antibiotic therapy is initiated to address this risk. The team emphasizes the importance of vigilant monitoring and reassessment to tailor the treatment plan effectively, recognizing the delicate balance required to manage the infant's complex and evolving clinical picture.